Addiction Medicine
From the Journals
New drug reporting limit may overlook cannabis in children
“Confirming THC-COOH in children’s and adolescents’ urine may be relevant at concentrations less than 15 ng/mL, particularly if child protection...
Latest News
Most effective meds for alcohol use disorder flagged
Acamprosate and naltrexone had the highest strength of evidence and were both associated with improvement in drinking outcomes.
News from the FDA/CDC
High school students using less tobacco, vape products, CDC report shows
“Sustained efforts to prevent initiation of tobacco product use among young persons and strategies to help young tobacco users quit are critical...
Commentary
Perinatal depression rarely stands alone
Major depressive disorder is the most common mental health condition during the perinatal period and is often comorbid.
Conference Coverage
Teens have easy online access to Delta-8 cannabinoid products
Only 2 websites out of 45 had any mechanism for verifying customers’ ages, and most of the cheapest products sold were edibles in colorful...
From the Journals
Telehealth linked to better opioid treatment retention
There was no increased risk of nonfatal overdose with telehealth treatment.
Latest News
Predictors of prescription opioid overdose
“Awareness of, and attention to, several patient and prescription characteristics may help reduce the risk of opioid overdose among people living...
Latest News
New Canadian guidelines for high-risk drinking, AUD
All patients with AUD should be referred for psychosocial treatment, and those with moderate to severe AUD should be offered naltrexone,...
From the Journals
LSD use triples among young adults with depression
The increase in LSD use was higher among those earning less than $75,000 per year.
Commentary
Why legal pot makes this physician sick
Cannabis-related emergency department visits from all acute-care hospitals in California increased by 1,808% from 2005 to 2019 in patients aged 65...
Conference Coverage
Cannabis use growing among menopausal women
Cannabis is being increasingly marketed for treating menopause-related and aging-related symptoms.